Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas Mika Insider Profile
4 Followers
Thomas Mika, Director, CEO and President, Director at Rennova Health, holds 303.84K shares in Rennova Health (Ticker: RNVA), holds ― shares in NanoVibronix (Ticker: NAOV).
Thomas Mika has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thomas Mika holds in companies
Most Profitable Insider Trade
The most profitable trade made by Thomas Mika
Thomas Mika's Trading History
Rennova Health
Jan 29, 2014
Director, CEO and President, Director
Uninformative Buy
―
$8.81K
NanoVibronix
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Thomas Mika's performance on stock
You May Also Like
Thomas Mika insider profile FAQ
What is the percentage of profitable transactions made by Thomas Mika?
The percentage of profitable transactions made by Thomas Mika is ―.
What is the average return per transaction made by Thomas Mika?
The average return per transaction made by Thomas Mika is ―.
What stocks does Thomas Mika hold?
Thomas Mika holds: RNVA, NAOV stocks.
What was Thomas Mika’s latest transaction?
Thomas Mika latest transaction was an Uninformative Buy of ―.
What was Thomas Mika's most profitable transaction?
Thomas Mika’s most profitable transaction was an Informative Buy of RNVA stock on November 15, 2009. The return on the trade was -62.70%.
What is Thomas Mika's role in Rennova Health?
Thomas Mika's role in Rennova Health is Director, CEO and President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.